Source: Seeking Alpha

Adynxx: Adynxx reports Q3 results

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

1-25

President & CEO

Rick Orr

CEO Approval Rating

69/100

Adynxx is a clinical-stage pharmaceutical company that focuses on developing pain management drugs.